NXTCL:STO
NextCell Pharma AB
SEK 0.24
arrow_downward
-0.41%(-0.0010) 1D
ኖቬም 18, 1:34:38 ከሰዓት ጂ ኤም ቲ+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK 0.23
High
SEK 0.25
Low
SEK 0.23
Mkt. cap
31.35 ሚ
Avg. vol.
1.01 ሚ
Volume
48.48 ሺ
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39 ሚ
No. of employees
21
Open
SEK 0.23
High
SEK 0.25
Low
SEK 0.23
Mkt. cap
31.35 ሚ
Avg. vol.
1.01 ሚ
Volume
48.48 ሺ
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39 ሚ
No. of employees
21
News stories
From web sources and news partners
ChartMill
·
ከ45 ደቂቃዎች በፊት
S&P 500 Premarket Movers on Nov. 18
TradingView
·
ከ30 ደቂቃዎች በፊት
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
The Motley Fool
·
ከ25 ደቂቃዎች በፊት
Investors Love the S&P 500 Index. Here’s Why I Don’t.
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
Founded19 ማርች 2014
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitenextcellpharma.com